entertainment -WSS

entertainment

author：focus 2025-09-29 21:14:56 - browse：4343

inflamed intestine on a dark blue background — biotech coverage from STAT — Adobe

What happens after you close a nearly $11 billion acquisition?

Well, for Prometheus Therapeutics’ former CEO Mark McKenna, there was a brief vacation. But within weeks of the company’s acquisition by Merck closing last June, he was thinking about ideas for the future.

Investors were floating ideas by him. McKenna discussed possibilities with his teenagers and Prometheus’ chief scientific officer. This “summer of discovery,” as McKenna called it, brought him back to the immune system. Prometheus and some other companies have been able to capitalize on creating treatments for conditions like inflammatory bowel disease and psoriasis, while arthritis medications like Humira have brought in billions of dollars in sales. But the field hadn’t quite received the same attention as missions to cure cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Why palliative psychiatry is worth discussing

hotspot

WSS

Obesity drugs seen as possible treatment for liver disease MASH

PBM reform efforts get punted in Congress

Dario to buy mental health app maker Twill in cash and stock deal

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Digital health funding stays low as a new reality sets in

focus

entertainment

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A new nitrogen execution bill also undermines medical licensing

Sports medicine is finally prioritizing gender equality

The Harvard botanist who searched for psychedelics in the Amazon

Dobbs anniversary: the lost opportunity of abortion as health care

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Novavax promises a turnaround & Lilly roils the obesity market

Why palliative psychiatry is worth discussing

Jerome Adams on the need for new antivirals for Covid

A new nitrogen execution bill also undermines medical licensing

explore

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Women's World Cup brings attention to abuse in soccer

Medicare inequities exacerbate Puerto Rico’s health disparities

Why palliative psychiatry is worth discussing

Why palliative psychiatry is worth discussing

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

leisure time

hotspot

hotspot

explore